Cytosorbents's total assets for Q2 2025 were $47.99M, a decrease of -5.50% from the previous quarter. CTSO total liabilities were $36.40M for the fiscal quarter, a 0.46% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.